2019年中药类商品进出口形势分析  

Analysis of TCM Import and Export Situation in 2019

作　　者：柳燕[1] 于志斌[1] LIU Yan;YU Zhi-bin(China Chamber of Commerce for Import&Export of Medicine&Health Products,Beijing 100010,China)

机构地区：[1]中国医药保健品进出口商会,北京100010

出　　处：《中国现代中药》2020年第3期342-347,共6页Modern Chinese Medicine

摘　　要：受世界贸易形势复杂多变的影响,2019年对外贸易整体增长放缓。然而,在国家系列促进外贸、稳定增长措施的作用下,医药行业对外贸易实现平稳发展。2019年中药类商品贸易总额达61.75亿美元,同比增长7.05%。美国仍是我国中药类商品出口的第一大市场。中药材及饮片出口呈现较强的“抗压性”,出口额11.37亿美元,同比增长10.32%。2020年,受新型冠状病毒肺炎在全球蔓延的影响,中药类商品的外贸履约或将受到冲击,但是对中药类商品需求的增长或能带来新的机遇。Affected by the complex and changing world trade situation,China's overall foreign trade growth will slow down in 2019.However,under the action of a series of the national measures aiming at promoting the foreign trade and stabilizing the growth,China's pharmaceutical industry has achieved steady development in foreign trade.In 2019,the total trade volume of Chinese medicine products reached US$6.175 billion,a year-on-year increase of 7.05%.The United States is still the largest market for Chinese medicine exports.The export of Chinese medicinal materials and decoction pieces showed strong resilient,with the export value of US$1.137 billion,a year-on-year increase of 10.32%.In 2020,due to the global spread of COVID-19,foreign trade compliance of Chinese medicine products may be impacted,but the increase in demand for Chinese medicine products may bring new opportunities.

关 键 词：中药 保健品 提取物 贸易 进出口 

分 类 号：R282[医药卫生—中药学] F763[医药卫生—中医学]